Dermatitis Global Market Report 2021 : COVID-19 Impact And Recovery
The Business Research Company’s Dermatitis Global Market Report 2021 – COVID-19 Impact And Recovery
LONDON, GREATER LONDON , UK, September 7, 2021 /EINPresswire.com/ — Growth in the global atopic dermatitis market is primarily driven by the increasing global prevalence of the disease. Prevalence of dermatitis in children is estimated to be around 15-20% while it is 1-3% in adults. The rising cases of food allergies are adding to the prevalence of dermatitis which ultimately leads to the increase in demand for the medicines to cure this disease. For example, according to the allergy asthma network 2020, approximately 31.6 million people in the United States have some form of atopic dermatitis. The prevalence of atopic dermatitis globally in children have 15-20 percent and in adults have 1 to 3 percent.
The global dermatitis market size is expected to grow from $4.82 billion in 2020 to $4.90 billion in 2021 at a compound annual growth rate (CAGR) of 1.7%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The contact dermatitis market size is expected to reach $5.91 billion in 2025 at a CAGR of 4.8%.
Read More On The Global Dermatitis Market Report:
https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report
Major players covered in the global dermatitis drugs market are LEO Pharma A/S, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc. and Sanofi S.A.
Strict government regulations are one of the restraints for the dermatitis drug market. Atopic Dermatitis (eczema) usually occurs at a very early stage (0-5 years). In order to find the efficacy and efficiency of drug, it has to be tried on every type of patients. The effects of certain drugs in adults are quite different than in children, as a reason result of the clinical trial cannot be used for the production of drug that will be served to the children. This hinders the research and requires more efforts in clearing regulation set by FDA. For example, as the patient population is largely children, FDA in its CFR Code Title 21, Part 50 Protection of Human Subjects, and subpart D has laid down guidelines for the additional safeguard for children in clinical investigation. The regulation is in compliance with Children’s Health Act of 2000 that requires all the children subjected to clinical trial be given additional protection.
The global dermatitis market is segmented by drug class into corticosteroids, emollients/moisturizers, antihistamines, calcineurin inhibitors, antibiotics, immunomodulators, interleukin inhibitors, by distribution channel into hospital, retail pharmacies, drug stores, online or mail pharmacies, by route of application into topical, oral, injectable, and by application into cancer, blood disorders, chronic diseases, infectious diseases.
Dermatitis Global Market Report 2021 – By Drug Class (Corticosteroids, Emollients/Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors), By Distribution Channel (Hospital, Retail Pharmacies, Drug Stores, Online Or Mail Pharmacies), By Route Of Application (Topical, Oral, Injectable), By Application (Cancer, Blood Disorders, Chronic Diseases, Infectious Diseases), COVID-19 Impact And Recovery is one of a series of new reports from The Business Research Company that provides dermatitis market overview, forecast dermatitis market size and growth for the whole market, dermatitis market segments, and geographies, dermatitis market trends, dermatitis market drivers, restraints, leading competitors’ revenues, profiles, and market shares.
Request For A Sample Of The Global Dermatitis Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2413&type=smp
Here Is A List Of Similar Reports By The Business Research Company:
Dermatology Drugs Global Market Report 2021 – By Type (Acne, Dermatitis, Psoriasis, Other Drugs for Dermatology Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), COVID-19 Impact And Recovery
https://www.thebusinessresearchcompany.com/global-market-reports
Metabolic Disorders Drugs Global Market Report 2021 – By Type (Acne, Dermatitis, Psoriasis, Other Drugs for Dermatology Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), COVID-19 Impact And Recovery
https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report-2020-30-covid-19-impact-and-recovery
Dry Eye Medication Market – By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous and Evaporative) By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies) By Delivery System (Liquid, Gel, Ointment, Others) And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/dry-eye-medication-market
Interested to know more about The Business Research Company?
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
Or get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
The Business Research Company
Email: info@tbrc.info
Follow us on LinkedIn: https://bit.ly/3b7850r
Follow us on Twitter: https://bit.ly/3b1rmjS
Check out our Blog: http://blog.tbrc.info/
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn
